Published January 1, 2017 | Version v1
Journal article Open

Mitochondrial depletion in CD4(+) and CD19(+) peripheral lymphocytes in early stage Alzheimer's disease

  • 1. Yeditepe Univ, Dept Biotechnol, Inonu Mahallesi Kayisdagi Caddesi 326A 26 Agustos, TR-34755 Istanbul, Turkey
  • 2. Yeditepe Univ Hosp, Dept Neurol, Istanbul, Turkey
  • 3. Fatih Sultan Mehmet Training & Res Hosp, Istanbul, Turkey
  • 4. Maltepe Univ Hosp, Dept Neurol, Istanbul, Turkey

Description

Alzheimer's disease (AD) may be associated with mitochondrial defects. The aim of the present study was to investigate changes in mitochondrial abundance in peripheral lymphocytes of early and late stage AD patients. We analysed levels of mitochondrial DNA (mtDNA) and mean fluorescence intensity (MFI) of the mitochondria- specific antibody 113-1 in CD4(+), CD8(+), CD19(+) and CD56(+ )peripheral lymphocytes of early and late stage AD by quantitative real-time PCR and flow cytometry, respectively. In early stage AD, the levels of mtDNA were significantly decreased in CD4(+), CD19(+) and CD56(+) peripheral lymphocytes while the MFI of 113-1 staining was significantly decreased in CD4(+) and CD19(+ )cells. Thus, CD4(+) and CD19(+) peripheral lymphocytes of early stage AD patients exhibit mitochondrial depletion, as seen both at the level of DNA and protein.

Files

bib-b688eb8a-7a66-418e-a310-e0f7144d081e.txt

Files (256 Bytes)

Name Size Download all
md5:0d1b8a091bb96cb764e79f28f288bb2c
256 Bytes Preview Download